Blood Processing Devices and Consumables Market Trends, Share & Demand by 2034

The Blood Processing Devices and Consumables Market size is expected to rise from US$ 58.00 Billion in 2025 to US$ 103.54 Billion in 2034, with a CAGR of 6.65% from 2026 to 2034. Factors driving the growth include increased levels of transfusion, growing use of blood components therapy, and an increasing level of modernization in blood banks, hospitals, and diagnostic laboratories that need robust instruments and consumables for blood-related processes.

North America will continue to be a structurally developed market, with factors aiding the Blood Processing Devices and Consumables Market size including centralization of blood services, high procedure intensity in hospitals, and early implementation of automated component processing. North America is anticipated to experience a 5.8–6.3% CAGR from 2026 to 2034, driven by replacement demand, plasma collection systems, and hospital compliance updates.

Blood Processing Devices And Consumables Market Assessment and Insights

Technology has evolved from manual centrifugation to integrated systems including collection, separation, leukoreduction, pathogen reduction, and traceability. The Blood Processing Devices and Consumables Market growth will be driven by component therapy, plasma fractionation, and Point-of-Care (POC) applications, whereas production dynamics will favor manufacturers with proven sterile manufacturing capabilities, distribution channels across global regions, and documentation. Consumables will be less susceptible to changes in volume as each test, donation, and transfusion uses controlled single-use product routes.

During the forecast period, emerging geographies will drive investment flows through blood safety policies and donor screening, along with the development of regional blood center infrastructure. Growing regulatory pressure on haemovigilance, cold chain management, and infection prevention will drive demand for consumables and automated devices that comply with these regulations. Manufacturers are developing local service capabilities as part of their strategy to reduce machine downtimes, train users and influence procurement in underpenetrated hospitals and laboratories.

Blood Processing Devices And Consumables Market Report Scope

Blood Processing Devices And Consumables Market Analysis

Increased demand for transfusion medicine that is specific to components, procedures, and higher standards of control is driving market expansion. With many blood systems processing high volumes of blood donations globally, the WHO estimates that more than 120 million donations occur each year worldwide. Efficiency and safety become vital procurement considerations in this case, thus adding momentum to the Blood Processing Devices and Consumables Market.

Ecosystem participants include donor centers, hospitals, diagnostic labs, plasma processors, regulatory bodies, logistics companies, and device manufacturers. Companies having wider disposable product lines will enjoy favorable supply dynamics since validated bags, filters, tubing sets, reagents, and anticoagulants generate predictable revenue streams. Separation equipment as well as software-driven solutions bring about differentiation, however, their adoption depends on availability of personnel and lower wastage rates demonstrated.

Platform scope, account retention, and service capability continue to play important roles in competitive positioning. In the Blood Processing Devices and Consumables Market Analysis, larger companies leverage diagnostics, automation, and transfusion medicine product lines to safeguard their accounts, while specialists capitalize on niche areas such as apheresis, cell processing, blood typing, and sterilization systems.

Abbott Laboratories and F. Hoffmann-La Roche Ltd improve clinical lab integration capabilities; Bio-Rad Laboratories, Inc. and Immucor, Inc. provide services for immunohematology testing; Terumo Corporation, Haemonetics Corporation, Grifols, S.A., Macopharma SA, bioMérieux SA, Danaher Corporation, Becton, Dickinson and Company, and ThermoGenesis Holdings, Inc. leverage automation, consumables, and specialized technologies for competition. Strategic investments will continue to be focused on automation, reagent efficacy, pathogen protection, and local production strength.

Blood Processing Devices And Consumables Market: Strategic Insights

Regional Insights

North America Blood Processing Devices and Consumables Market

North America accounted for 38–40% share in 2025 and is expected to grow at a CAGR of 5.8–6.3% during 2026–2034. The region benefits from highly regulated blood establishments, frequent component therapy use, and strong adoption of automated apheresis and platelet processing. Blood Processing Devices and Consumables Market share is supported by mature hospital transfusion services and independent donor networks.

The procurement process now factors in workflow standardization, security, remote services, and inventory transparency. The replacement cycle is determined by the age of the centrifuges, the requirement for software-based traceability, and the need to minimize wastage of platelets and plasma. The Canadian system of blood management and the US plasma donation network make regional usage of consumables and automated collection technology easier.

U.S. Blood Processing Devices and Consumables Market

North America was led by the US which held 82-86% share in the year 2025 and is expected to maintain a growth rate of 5.7-6.2% CAGR during 2026-2034. Driving factors are high volume of surgeries, trauma care, oncological transfusions, and plasma donations. The CDC points out that the demand for blood transfusion devices in the US includes tens of thousands of units of red cells, platelets, and plasma every day.

Players' participation is widespread, including Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Haemonetics Corporation, Immucor, Inc., and Terumo Corporation. Applications are moving toward automated platelet production, donor testing, electronic crossmatch assistance, and hospital blood management solutions that decrease improper utilization but improve documentation and quality control spending.

Europe Blood Processing Devices and Consumables Market

Europe has accounted for 27–30% market share in 2025, and is anticipated to grow at CAGR of 6.0–6.5% during 2026-2034. Germany accounts for highest growth, due to large investment in healthcare, hospital laboratory infrastructure, and blood safety regulations. UK focuses on centralized procurement, NHS transformation, and affordable technology for sickle cell disease and transfusion.

Germany dominates the market in replacement and automation, whereas France has a well-organized national blood system, which facilitates standardization of consumables and component preparation. Italy and Spain are developing their regional transfusion networks along with laboratory processes in light of labor issues, traceability, and recovery of patients from surgeries. Harmonized regulations in Europe drive the need for validated instruments, assays for donor screening, and quality consumables.

APAC Blood Processing Devices and Consumables Market

The APAC region held 22-25% market share in 2025 and is predicted to register a CAGR of 8.0-8.6% in 2026-2034. The largest country in the region is China owing to increasing hospital establishments, blood safety initiatives, and rising demand for therapies based on plasma derivatives. Japan and South Korea prioritize automation, whereas India increases testing and separation capabilities.

Australia offers a developed example of quality management and centralization in supply. Southeast Asia prioritizes donor recruitment and the modernization of blood banks. Some industrial factors are local manufacturing, digitized laboratories, and public procurement initiatives. Universal health coverage and safe transfusions policy are expected to drive demand for medical devices and accessories.

Middle East & Africa Blood Processing Devices and Consumables Market

The Middle East & Africa market will have a CAGR of 6.8–7.4% for the period of 2026-2034, led by Saudi Arabia. Health infrastructure investments in the Gulf region provide development in hospital labs, trauma centers, and elective surgeries. On the other hand, the UAE focuses on expanding private hospitals and internationally accredited transfusion services.

South Africa continues to be the most advanced Sub-Saharan region owing to the presence of well-established blood service and diagnostic facilities. RoMEA requirements depend upon the inadequacy of safe blood access, cold chain, and donors' availability. The energy-based financial capacity in the Gulf region allows for the upgrade of equipment, whereas the African programs focus on processing, storage, and screening.

Segmentation Analysis

Product

Product is expected to grow at a CAGR of 6.3–6.8% during 2026–2034 as buyers balance capital-equipment modernization with predictable recurring purchases. Blood Processing Devices and Consumables Market scope under this segment includes automation, collection, separation, testing, storage, and transfusion support. Adoption is influenced by sterility assurance, regulatory documentation, throughput, compatibility with laboratory systems, and cost per processed unit.

• Devices: Devices include centrifuges, automated blood processors, apheresis systems, freezers, sealers, and mixers. Demand is linked to replacement cycles, workflow automation, reduced manual variability, and quality assurance needs in hospitals and blood centers.
• Consumables: Consumables include blood bags, filters, tubing sets, reagents, anticoagulants, sample containers, and collection accessories. Their strategic importance comes from recurring usage, infection control requirements, component processing volumes, and validated supplier relationships.

End-use

End-use is projected to grow at a CAGR of 6.6–7.1% during 2026–2034, reflecting wider adoption across clinical and laboratory settings. Hospitals and clinics prioritize transfusion readiness, surgical support, and emergency inventory, while laboratories focus on donor testing, compatibility testing, and screening throughput. Growth is shaped by decentralization of diagnostics and stricter quality documentation.

• Hospitals & Clinics: Hospitals and clinics remain central users because transfusions support surgery, trauma, cancer care, obstetrics, and chronic anemia management. Their purchasing emphasizes reliability, inventory control, staff safety, and integration with transfusion protocols.
• Diagnostic Laboratories: Diagnostic laboratories are expanding their role in blood grouping, infectious disease screening, antibody identification, and compatibility services. Their demand pattern favors automated analyzers, validated reagents, sample traceability, and higher-throughput platforms.

Opportunity Snapshot

Blood Processing Devices And Consumables Market Growth Drivers and Impact Analysis

Rising Need for Safe and Component-Based Transfusion

There is an increase in the operational intensity of the blood services sector through component therapy, as one unit of collected blood may be prepared into multiple components with distinct clinical uses. This will drive up the need for automation, filters, sterile containers, and proper storage. These effects will have their most significant effect in those locations that rely on trauma network treatment, oncology care, transplantation, and complex surgical procedures, which are all areas where red cells, plasma, cryoprecipitate, and platelets are in demand. In addition, quality systems increase demand for documentable products due to the risks associated with transfusion errors.

Expansion of Plasma Collection and Fractionation Demand

Plasma-derived therapies for immunology, neurology, hematology, and critical care are increasing demand for reliable plasmapheresis and plasma handling systems. This creates a direct pull for collection devices, disposable kits, anticoagulants, containers, and cold-chain compatible consumables. This effect is especially pronounced in countries like the USA and some other European countries due to efficient infrastructure for fractionation supply chains. In addition, emerging markets are seeking better ways to develop their domestic plasma programs to reduce import dependence. Supply companies which can offer validated plasma workflows can help in generating consistent revenues for such centers.

Automation Pressure from Workforce and Quality Constraints

Laboratories and blood banks face a shortage of skilled manpower, increasing documentation needs, and a need to reduce processing variation. This challenge is solved by automation through the standardization of centrifuging, separation, aliquoting, testing, tracing and inventory procedures. Automation does not only help increase efficiency but also helps achieve audit trails and reduces processing variation since the systems offer uniform quality of component products. In hospitals and laboratories, Total Cost of Ownership, which involves reducing labor costs, waste, and downtime, is increasingly becoming part of procurement considerations. Vendors with training, servicing and interconnectivity software capability stand higher chances of winning contracts.

Blood Processing Devices And Consumables Market Future Trends

Digital Traceability Across Blood Processing Networks

Blood Processing Devices and Consumables Market trends are shifting toward end-to-end digital visibility, linking donor records, collection devices, testing platforms, storage systems, and transfusion events. Future systems will rely more on barcoding, RFID, cloud-enabled dashboards, and interoperable laboratory information systems to reduce errors and support haemovigilance. This trend will also strengthen demand for consumables that carry validated identifiers and remain compatible with scanning, tracking, and automated storage. Suppliers with cybersecurity-ready software and compliant data architecture will gain stronger differentiation as regulators and buyers demand transparent chain-of-custody evidence.

Greater Convergence of Blood and Cell Processing

The boundary between transfusion medicine and cell therapy manufacturing is becoming less distinct as hospitals and specialist centers process blood-derived cells for advanced therapies. Devices originally used for apheresis, cell separation, cryopreservation, and sterile transfer are increasingly relevant to regenerative medicine and immunotherapy workflows. This will encourage suppliers to design modular platforms that serve both routine blood processing and high-value cell processing. Consumables will need stronger sterility assurance, closed-system compatibility, and documentation for regulated manufacturing environments. The trend supports premium pricing where systems can address clinical transfusion and advanced therapy infrastructure simultaneously.

Blood Processing Devices And Consumables Market Opportunities

Automation Upgrades in Mid-Sized Blood Centers

Mid-sized blood centers present a practical investment opportunity because many still rely on semi-manual processing while facing rising demand for platelets, plasma, and standardized components. Blood Processing Devices and Consumables Market Forecasts indicate that vendors can unlock adoption by offering phased automation, financing support, service contracts, and staff training rather than only high-cost full-system replacements. Modular centrifugation, automated separation, and software-linked inventory tools can improve productivity without overwhelming capital budgets. Suppliers that document reduced wastage, faster turnaround, and fewer manual errors will be well positioned to convert procurement interest into multiyear platform and consumable contracts.

Localized Consumable Manufacturing in Emerging Markets

Emerging markets are seeking more resilient supply chains for blood bags, tubing, filters, reagents, and sample handling products. Localized manufacturing or regional finishing can reduce import exposure, shorten lead times, and improve public tender competitiveness. This opportunity is particularly relevant in Asia Pacific, the Middle East, and Africa, where blood system modernization is expanding but procurement budgets remain sensitive. International suppliers can use partnerships, technology transfer, and quality-system support to build local credibility while protecting product standards. The strongest returns are likely where governments prioritize universal health coverage, domestic medical device production, and safer transfusion access.

Recent Developments

• February 2026: Haemonetics Corporation received FDA clearance for its NexSys PCS Plasma Collection System with Persona PLUS Technology, advancing its plasma collection platform and reinforcing its position in donor-center automation, where throughput, donor experience, and collection efficiency remain central purchasing criteria.
• October 2025: Terumo Blood and Cell Technologies supported The Blood Center in New Orleans in deploying the Reveos Automated Blood Processing System and Lumia Software Platform, making it the second US blood center to implement this FDA-cleared automation for whole-blood-derived platelet production.
• March 2025: Grifols, S.A. signed a strategic agreement with Inpeco to deliver transfusion medicine laboratory automation, combining Grifols diagnostic instrumentation and reagents with Inpeco’s FlexLab X robotics and software to improve sample routing, traceability, and screening laboratory efficiency.